GenFleet Therapeutics rallies $75m Series C
GenFleet Therapeutics, a clinical-stage biotechnology company with a focus on therapies in oncology and immunology, has raised $75 million in Series C financing.
GenFleet Therapeutics, a clinical-stage biotechnology company with a focus on therapies in oncology and immunology, has raised $75 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination